179 related articles for article (PubMed ID: 27491374)
21. Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
Rodríguez Laval V; Pavel M; Steffen IG; Baur AD; Dilz LM; Fischer C; Detjen K; Prasad V; Pascher A; Geisel D; Denecke T
Neuroendocrinology; 2018; 106(2):139-147. PubMed ID: 28384635
[TBL] [Abstract][Full Text] [Related]
22. Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.
de Mestier L; Savagner F; Brixi H; Do Cao C; Dominguez-Tinajero S; Roquin G; Goichot B; Hentic O; Dubreuil O; Hautefeuille V; Walter T; Cadiot G
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1673-e1682. PubMed ID: 33382891
[TBL] [Abstract][Full Text] [Related]
23. Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.
Søndenaa K; Sen J; Heinle F; Fjetland L; Gudlaugsson E; Syversen U
World J Surg; 2004 Sep; 28(9):890-5. PubMed ID: 15593463
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of chromogranin A, neuron-specific enolase and 5-hydroxyindolacetic acid measurements in patients with malignant carcinoids.
Manfé AZ; Norberto L; Marchesini M; Lumachi F
In Vivo; 2011; 25(6):1027-9. PubMed ID: 22021701
[TBL] [Abstract][Full Text] [Related]
25. Urinary 5-HIAA excretion is not increased in patients with head and neck paragangliomas.
van Hulsteijn LT; van Duinen N; Romijn JA; Smit JW; Corssmit EP
Int J Biol Markers; 2012 Jul; 27(2):e160-3. PubMed ID: 22653742
[TBL] [Abstract][Full Text] [Related]
26. Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
Sen Gupta P; Grozinsky-Glasberg S; Drake WM; Akker SA; Perry L; Grossman AB; Druce MR
Clin Endocrinol (Oxf); 2014 Feb; 80(2):246-52. PubMed ID: 23790044
[TBL] [Abstract][Full Text] [Related]
27. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.
Laskaratos FM; Diamantopoulos L; Walker M; Walton H; Khalifa M; El-Khouly F; Koffas A; Demetriou G; Caplin M; Toumpanakis C; Mandair D
Neuroendocrinology; 2018; 106(4):366-380. PubMed ID: 29320779
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors.
Bajetta E; Ferrari L; Martinetti A; Celio L; Procopio G; Artale S; Zilembo N; Di Bartolomeo M; Seregni E; Bombardieri E
Cancer; 1999 Sep; 86(5):858-65. PubMed ID: 10463986
[TBL] [Abstract][Full Text] [Related]
30. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive.
Pavel M; Jann H; Prasad V; Drozdov I; Modlin IM; Kidd M
Neuroendocrinology; 2017; 104(2):170-182. PubMed ID: 27078712
[TBL] [Abstract][Full Text] [Related]
31. Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system.
Ezziddin S; Adler L; Sabet A; Pöppel TD; Grabellus F; Yüce A; Fischer HP; Simon B; Höller T; Biersack HJ; Nagarajah J
J Nucl Med; 2014 Aug; 55(8):1260-6. PubMed ID: 24876204
[TBL] [Abstract][Full Text] [Related]
32. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and predictive biomarkers in neuroendocrine tumours.
Chan DL; Clarke SJ; Diakos CI; Roach PJ; Bailey DL; Singh S; Pavlakis N
Crit Rev Oncol Hematol; 2017 May; 113():268-282. PubMed ID: 28427516
[TBL] [Abstract][Full Text] [Related]
34. [Pitfalls in the diagnosis of carcinoids in patients treated with aminosalicylates].
Dastych M; Dastych M; Zboril V; Senkyrík M; Starý K; Cáslavský J; Chmelík J
Vnitr Lek; 2003 Mar; 49(3):200-4. PubMed ID: 12733495
[TBL] [Abstract][Full Text] [Related]
35. Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.
Zuetenhorst JM; Korse CM; Bonfrer JM; Peter E; Lamers CB; Taal BG
Clin Chem; 2004 Sep; 50(9):1634-9. PubMed ID: 15247155
[TBL] [Abstract][Full Text] [Related]
36. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP
Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693
[TBL] [Abstract][Full Text] [Related]
37. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
38. Carcinoid tumors--somatostatine in the diagnosis and therapy.
Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J
Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumours of the small bowel: interpretation of raised circulating chromogranin A, urinary 5 hydroxy indole acetic acid and circulating neurokinin A.
Ardill JE; Armstrong L; Smye M; Doherty R; McCance DR; Johnston BT
QJM; 2016 Feb; 109(2):111-5. PubMed ID: 25979268
[TBL] [Abstract][Full Text] [Related]
40. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid.
Lionetto L; Lostia AM; Stigliano A; Cardelli P; Simmaco M
Clin Chim Acta; 2008 Dec; 398(1-2):53-6. PubMed ID: 18760269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]